Dr. Mark A Ebadi , MD
Specialist • Denver, CO
125 Rampart Way, Suite 200
Denver, CO 802306406
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on January 31, 2006; this date does not establish years in practice.
-
Published CMS data list 11,083 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 95165 — Professional service for preparation and provision of 1 or more antigens: 5,907 service units.
- 95004 — Test for allergy using allergenic extract: 3,227 service units.
- 95117 — Professional service for multiple injections of allergen: 502 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 13 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,589 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Ipratropium Bromide — 402 prescription fills, including refills.
- Symbicort (Budesonide/Formoterol Fumarate) — 186 prescription fills, including refills.
- Advair Hfa (Fluticasone Propion/Salmeterol) — 183 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 21 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 90% of clinicians listed under Specialist in Denver, CO (2024, 16 clinicians with data). Median for this group: 1,447. Middle half: 388 to 4,525.
More Medicare Part B services than 90% of clinicians listed under Specialist in Colorado (2024, 80 clinicians with data). Median for this group: 1,101. Middle half: 290 to 2,874.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 13,147 in 2020 to 11,083 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
125 Rampart Way
Suite 200
Denver, CO 802306406
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Colorado Allergy And Asthma Centers Pc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of Nebraska College Of Medicine
1997
What Public CMS Data Show
Specialist: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
672 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $185,780 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $132,904 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
2,206 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$472,108 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $564.74 across 25 records.
By nature of payment
- Food and Beverage: $530.74 across 24 records.
- Education: $34.00 across 1 record.
Reporting-company totals (3 largest of 12)
- AstraZeneca Pharmaceuticals LP: $135.51 across 6 records.
- Novartis Pharmaceuticals Corporation: $109.71 across 4 records.
- Amgen Inc.: $59.39 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
29 years (graduated 1997)
CMS Doctors and Clinicians data list 1997 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Ebadi has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Ebadi as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Denver and Colorado
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 90% of clinicians listed under Specialist in Denver, CO (2024, 16 clinicians with data). Median for this group: 1,447. Middle half: 388 to 4,525.
More Medicare Part B services than 90% of clinicians listed under Specialist in Colorado (2024, 80 clinicians with data). Median for this group: 1,101. Middle half: 290 to 2,874.
Medicare-allowed amount
Close to the middle for clinicians listed under Specialist in Denver, CO (2024, 16 clinicians with data). Median for this group: $154,073. Middle half: $13,298 to $348,354.
A higher Medicare-allowed amount than 75% of clinicians listed under Specialist in Colorado (2024, 80 clinicians with data). Median for this group: $51,585. Middle half: $16,527 to $179,592.
Paid by Medicare
Close to the middle for clinicians listed under Specialist in Denver, CO (2024, 16 clinicians with data). Median for this group: $110,785. Middle half: $10,144 to $267,457.
A higher Medicare payment amount than 70% of clinicians listed under Specialist in Colorado (2024, 80 clinicians with data). Median for this group: $38,766. Middle half: $11,235 to $133,149.
Medicare Part D prescriptions
More Part D prescriptions than 85% of clinicians listed under Specialist in Denver, CO (2024, 16 clinicians with data). Median for this group: 490. Middle half: 137 to 1,338.
More Part D prescriptions than 85% of clinicians listed under Specialist in Colorado (2024, 68 clinicians with data). Median for this group: 197. Middle half: 65 to 692.
Part D drug cost
A higher Part D drug cost than 85% of clinicians listed under Specialist in Denver, CO (2024, 16 clinicians with data). Median for this group: $90,979. Middle half: $8,298 to $228,572.
A higher Part D drug cost than 85% of clinicians listed under Specialist in Colorado (2024, 68 clinicians with data). Median for this group: $9,768. Middle half: $1,425 to $145,565.
228 active clinicians are listed under Specialist with a practice address in Denver, CO (1,105 in Colorado).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Denver
0.9% of these 228 clinicians have the CMS telehealth indicator.
8.8% of these 228 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 16% from 13,147 in 2020 to 11,083 in 2024.
- 2020: 13,147
- 2021: 13,046
- 2022: 14,651
- 2023: 13,369
- 2024: 11,083
-
Medicare-allowed amount
Medicare-allowed amount varied from year to year: $172,320 in 2020 and $185,780 in 2024.
- 2020: $172,320
- 2021: $185,884
- 2022: $258,853
- 2023: $203,757
- 2024: $185,780
-
Paid by Medicare
Paid by Medicare varied from year to year: $126,593 in 2020 and $132,904 in 2024.
- 2020: $126,593
- 2021: $137,947
- 2022: $194,482
- 2023: $147,698
- 2024: $132,904
-
Medicare Part D prescriptions
Medicare Part D prescriptions stayed about the same: 1,474 in 2020 and 1,589 in 2024.
- 2020: 1,474
- 2021: 1,291
- 2022: 1,240
- 2023: 1,478
- 2024: 1,589
-
30-day fills
30-day fills stayed about the same: 2,027 in 2020 and 2,206 in 2024.
- 2020: 2,027
- 2021: 1,761
- 2022: 1,805
- 2023: 2,081
- 2024: 2,206
-
Part D drug cost
Part D drug cost increased 15% from $409,468 in 2020 to $472,108 in 2024.
- 2020: $409,468
- 2021: $432,055
- 2022: $407,956
- 2023: $531,138
- 2024: $472,108
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $234.61 in 2021 to $564.74 in 2025.
- 2021: $234.61
- 2022: $416.61
- 2023: $464.01
- 2024: $243.20
- 2025: $564.74
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 25 records totaling $564.74.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Amgen Inc. |
Education
In-kind items and services
|
— | General | $34.00 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
AYVAKIT | General | $32.73 |
| CSL Behring |
Food and Beverage
In-kind items and services
|
Andembry | General | $31.81 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
— | General | $30.67 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
— | General | $28.89 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
TEZSPIRE | General | $26.61 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $25.63 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
TEZSPIRE | General | $25.39 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
— | General | $25.25 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
TEZSPIRE | General | $25.25 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
XOLAIR | General | $24.90 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
— | General | $24.82 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Xolair | General | $23.97 |
| CSL Behring |
Food and Beverage
In-kind items and services
|
Hizentra | General | $23.64 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $23.08 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FASENRA | General | $21.47 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
CIBINQO | General | $21.23 |
| Galderma Laboratories, L.P. |
Food and Beverage
In-kind items and services
|
NEMLUVIO | General | $20.16 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
CIBINQO | General | $19.70 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $19.33 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $18.03 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Xolair | General | $16.35 |
| Arcutis Biotherapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Zoryve | General | $15.06 |
| Organon LLC |
Food and Beverage
In-kind items and services
|
— | General | $4.51 |
| Organon LLC |
Food and Beverage
In-kind items and services
|
— | General | $2.26 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
95165
Professional service for preparation and provision of 1 or more antigens
|
5,907 | 367 | $22.00 | $14.65 |
|
95004
Test for allergy using allergenic extract
|
3,227 | 74 | $11.00 | $3.61 |
|
95117
Professional service for multiple injections of allergen
|
502 | 69 | $25.00 | $12.37 |
|
95115
Professional service for single injection of allergen
|
422 | 52 | $20.00 | $10.38 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
346 | 233 | $185.00 | $125.68 |
|
95024
Test for allergy using allergenic extract injected into skin
|
207 | 17 | $14.00 | $7.96 |
|
94010
Test to measure expiratory airflow and volume
|
118 | 87 | $63.00 | $27.18 |
|
96160
Administration and interpretation of patient-focused health risk assessment
|
89 | 71 | $6.00 | $3.02 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
88 | 88 | $275.00 | $163.58 |
|
96401
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
|
79 | 11 | $140.00 | $71.65 |
|
94375
Test to measure rate of airflow
|
41 | 35 | $68.00 | $38.80 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
38 | 38 | $125.00 | $89.14 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
19 | 16 | $245.00 | $176.87 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Ipratropium Bromide | Ipratropium Bromide | 402 | 16,864 | $14,963.46 | 110 |
| Symbicort | Budesonide/Formoterol Fumarate | 186 | 7,200 | $55,390.48 | 39 |
| Advair Hfa | Fluticasone Propion/Salmeterol | 183 | 7,260 | $81,104.32 | 40 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 143 | 3,616 | $3,845.13 | 67 |
| Montelukast Sodium | Montelukast Sodium | 140 | 7,230 | $1,097.26 | 35 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 103 | 4,770 | $18,482.79 | 31 |
| Qvar Redihaler | Beclomethasone Dipropionate | 77 | 2,680 | $25,065.09 | 18 |
| Prednisone | Prednisone | 50 | 328 | $118.87 | 42 |
| Azelastine Hcl | Azelastine Hcl | 47 | 1,640 | $1,921.92 | 14 |
| Dupixent Pen | Dupilumab | 39 | 1,260 | $165,499.28 | — |
| Fluticasone Propionate | Fluticasone Propionate | 37 | 1,530 | $839.71 | — |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 33 | 1,095 | $456.01 | 26 |
| Epinephrine | Epinephrine | 23 | 468 | $3,891.30 | 16 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 21 | 990 | $4,263.57 | — |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 19 | 176 | $196.31 | 17 |
| Dulera | Mometasone/Formoterol | 16 | 739 | $8,577.31 | — |
| Xolair | Omalizumab | 15 | 420 | $76,608.60 | — |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 15 | 600 | $5,440.24 | 11 |
| Arnuity Ellipta | Fluticasone Furoate | 14 | 480 | $3,643.22 | — |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 13 | 625 | $232.44 | — |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 13 | 580 | $470.62 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 174400000X
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - ALLERGY/IMMUNOLOGY
I20040212000189
CO
0446144182
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Colorado Allergy And Asthma Centers Pc
125 Rampart Way, Denver, CO 802306429
Phone: 7208587600
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Allergy & Immunology
Doctor of Medicine (M.D.)
Specialist
Doctor of Medicine (M.D.)
Specialist
Doctor of Medicine (M.D.)
Specialist
Doctor of Medicine (M.D.)
Specialist
Physician Assistant (Certified)
Specialist
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated January 31, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Specialists in Denver
- Dr. Nunthaporn Laoprasert, MD
- Dr. Paden Wolfe, DPT
- Dr. Samuel Chan, MD
- Nicole Mezo, PA
- Dr. Grant Olson, MD
- Dr. Barbara Schwartzberg, MD
Mailing Address
125 Rampart Way, Suite 100
Denver, CO 802306406
Phone: 7208587600